• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Implantation of an extravascular implantable cardioverter-defibrillator with an atrial leadless pacemaker: Wireless meets wireless to successfully avoid implantation of a transvenous system.

作者信息

Garcia-Montero Marta, Metzl Mark D, Dussault Charles, Raymond-Paquin Alexandre, Mondésert Blandine

机构信息

Montreal Heart Institute, Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Division of Cardiology, Endeavor Health-North Shore University Health System, Evanston, Illinois.

出版信息

HeartRhythm Case Rep. 2025 Feb 6;11(5):404-408. doi: 10.1016/j.hrcr.2025.01.020. eCollection 2025 May.

DOI:10.1016/j.hrcr.2025.01.020
PMID:40656003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12242966/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ce/12242966/c83647f725f1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ce/12242966/1a97effeebd7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ce/12242966/48c29da134c6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ce/12242966/27d1342287b3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ce/12242966/c83647f725f1/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ce/12242966/1a97effeebd7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ce/12242966/48c29da134c6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ce/12242966/27d1342287b3/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98ce/12242966/c83647f725f1/gr4.jpg

相似文献

1
Implantation of an extravascular implantable cardioverter-defibrillator with an atrial leadless pacemaker: Wireless meets wireless to successfully avoid implantation of a transvenous system.植入带有无导线心房起搏器的血管外植入式心脏复律除颤器：无线与无线相结合成功避免经静脉系统植入。
HeartRhythm Case Rep. 2025 Feb 6;11(5):404-408. doi: 10.1016/j.hrcr.2025.01.020. eCollection 2025 May.
2
Performance and Safety of the Extravascular Implantable Cardioverter Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study.经长期随访的血管外植入式心脏复律除颤器的性能与安全性：关键研究的最终结果
Circulation. 2025 Jan 28;151(4):322-332. doi: 10.1161/CIRCULATIONAHA.124.071795. Epub 2024 Sep 26.
3
A Modular Communicative Leadless Pacing-Defibrillator System.一种模块化的通讯型无导线起搏除颤器系统。
N Engl J Med. 2024 Oct 17;391(15):1402-1412. doi: 10.1056/NEJMoa2401807. Epub 2024 May 18.
4
Simultaneous subcutaneous implantable cardioverter-defibrillator and leadless pacemaker implantation for patients at high risk of infection: a retrospective case series report.同时为感染高危患者植入皮下植入式心律转复除颤器和无导线起搏器：一项回顾性病例系列报告。
J Interv Card Electrophysiol. 2023 Nov 8. doi: 10.1007/s10840-023-01684-9.
5
A case report of pre-implantation feasibility test for combining leadless pacemaker and subcutaneous implantable cardioverter-defibrillator in adult congenital heart disease.成人先天性心脏病中无导线起搏器与皮下植入式心律转复除颤器联合植入前可行性测试的病例报告
J Cardiol Cases. 2024 Sep 12;30(6):189-192. doi: 10.1016/j.jccase.2024.08.007. eCollection 2024 Dec.
6
The modular cardiac rhythm management system: the EMPOWER leadless pacemaker and the EMBLEM subcutaneous ICD.模块化心脏节律管理系统：EMPOWER 无导线起搏器和 EMBLEM 皮下 ICD。
Herzschrittmacherther Elektrophysiol. 2018 Dec;29(4):355-361. doi: 10.1007/s00399-018-0602-y. Epub 2018 Oct 31.
7
Combined subcutaneous implantable cardioverter defibrillator and pacemaker devices in complex congenital heart disease: a single-center experienced based study.复杂先天性心脏病中皮下植入式心律转复除颤器与起搏器联合装置：一项基于单中心经验的研究
J Interv Card Electrophysiol. 2023 Oct 25. doi: 10.1007/s10840-023-01670-1.
8
Long-term performance of a novel communicating antitachycardia pacing-enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: A comprehensive preclinical study.一种新型具备抗心动过速起搏功能的可通信无导线起搏器和皮下植入式心律转复除颤器系统的长期性能：一项全面的临床前研究。
Heart Rhythm. 2022 May;19(5):837-846. doi: 10.1016/j.hrthm.2022.01.024. Epub 2022 Jan 21.
9
Left Ventricular Assist Device Implantation in the Presence of Substernal Extravascular Implantable Cardioverter-Defibrillator.在胸骨后血管外植入式心脏复律除颤器存在的情况下进行左心室辅助装置植入术。
JACC Case Rep. 2025 Jun 4;30(13):103508. doi: 10.1016/j.jaccas.2025.103508.
10
Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.皮下与经静脉植入式心脏除颤器治疗的比较：随机试验和倾向评分匹配研究的系统评价和荟萃分析。
J Am Heart Assoc. 2022 Jun 7;11(11):e024756. doi: 10.1161/JAHA.121.024756. Epub 2022 Jun 3.

本文引用的文献

1
First experience in simultaneous use of the extravascular implantable cardioverter-defibrillator and the leadless atrioventricular pacemaker.血管外植入式心脏复律除颤器与无导线房室起搏器同时使用的首次经验。
Kardiol Pol. 2024;82(12):1295-1296. doi: 10.33963/v.phj.102471. Epub 2024 Sep 6.
2
First-in-Man Surgical Extravascular-ICD Implantation: Suturing the Defibrillation Lead to the Heart Wall Post Device-Related Endocarditis.首例人体外科血管外植入式心律转复除颤器植入术：在与设备相关的心内膜炎后将除颤导线缝合至心脏壁。
JACC Case Rep. 2024 Aug 7;29(15):102424. doi: 10.1016/j.jaccas.2024.102424.
3
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.
经静脉植入式心脏复律除颤器的疗效和安全性。
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.